DK3177670T3 - Hyperforgrenet poly(beta-aminoester) til genterapi - Google Patents

Hyperforgrenet poly(beta-aminoester) til genterapi Download PDF

Info

Publication number
DK3177670T3
DK3177670T3 DK15745509.8T DK15745509T DK3177670T3 DK 3177670 T3 DK3177670 T3 DK 3177670T3 DK 15745509 T DK15745509 T DK 15745509T DK 3177670 T3 DK3177670 T3 DK 3177670T3
Authority
DK
Denmark
Prior art keywords
hyperforched
gentherapy
aminoester
beta
poly
Prior art date
Application number
DK15745509.8T
Other languages
English (en)
Inventor
Wenxin Wang
Dezhong Zhou
Original Assignee
Univ College Dublin Nat Univ Ireland Dublin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ College Dublin Nat Univ Ireland Dublin filed Critical Univ College Dublin Nat Univ Ireland Dublin
Application granted granted Critical
Publication of DK3177670T3 publication Critical patent/DK3177670T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A61K48/0041—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being polymeric
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
    • C08G63/685—Polyesters containing atoms other than carbon, hydrogen and oxygen containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002—Dendritic macromolecules
    • C08G83/005—Hyperbranched macromolecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Biological Depolymerization Polymers (AREA)
DK15745509.8T 2014-08-06 2015-08-06 Hyperforgrenet poly(beta-aminoester) til genterapi DK3177670T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1413907.5A GB201413907D0 (en) 2014-08-06 2014-08-06 Hyberbranched poly(beta-amino ester) for gene therapy
PCT/EP2015/068153 WO2016020474A1 (en) 2014-08-06 2015-08-06 HYPERBRANCHED POLY( ß -AMINO ESTER) FOR GENE THERAPY

Publications (1)

Publication Number Publication Date
DK3177670T3 true DK3177670T3 (da) 2020-04-27

Family

ID=51587799

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15745509.8T DK3177670T3 (da) 2014-08-06 2015-08-06 Hyperforgrenet poly(beta-aminoester) til genterapi

Country Status (14)

Country Link
US (1) US20170216455A1 (da)
EP (2) EP3177670B1 (da)
CY (1) CY1122850T1 (da)
DK (1) DK3177670T3 (da)
ES (1) ES2785248T3 (da)
GB (1) GB201413907D0 (da)
HR (1) HRP20200633T1 (da)
HU (1) HUE049704T2 (da)
LT (1) LT3177670T (da)
PL (1) PL3177670T3 (da)
PT (1) PT3177670T (da)
RS (1) RS60335B1 (da)
SI (1) SI3177670T1 (da)
WO (1) WO2016020474A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019084229A1 (en) 2017-10-27 2019-05-02 Massachusetts Institute Of Technology POLY (BETA-AMINO ESTERS) AND USES THEREOF
CN113260657A (zh) * 2018-10-12 2021-08-13 安瑞特基因有限公司 用于转染细胞的组合物和方法
EP3870629A1 (en) 2018-10-26 2021-09-01 Massachusetts Institute of Technology Polymer-lipids and compositions
BR112021009351A2 (pt) * 2018-12-28 2021-08-10 Amryt Genetics Ltd. métodos para formar poliplexos
EP3798250A1 (en) * 2019-09-25 2021-03-31 University College Dublin Hyperbranched cationic polymers useful as nucleic acid delivery vectors for transfecting
EP4034152A1 (en) 2019-09-25 2022-08-03 University College Dublin Nanoparticle compositions for gene therapy
CN110746599B (zh) * 2019-09-30 2021-06-18 苏州大学 具有高效基因递送能力的UV光响应性超支化聚β-氨基酯及其制备方法与应用
CN111135306B (zh) * 2020-01-19 2023-03-10 安阳师范学院 基于叶酸靶向聚乙二醇修饰型超支化聚胺制备叶酸和磁性双靶向型非病毒基因载体的方法
US20220287983A1 (en) * 2021-03-09 2022-09-15 Massachusetts Institute Of Technology Branched poly(-amino esters) for the delivery of nucleic acids
CN114106348B (zh) * 2021-11-12 2023-07-07 西安交通大学 苯硼酸修饰的胞内可降解超支化聚（β-氨基酯）及其制备方法和蛋白递送应用
EP4183884A1 (en) * 2021-11-19 2023-05-24 Branca Bunus Limited A method of preparing a fraction of a starting polymer vector for gene therapy
WO2023131648A1 (en) 2022-01-05 2023-07-13 Branca Bunus Limited Nanoparticulate compositions for gene therapy
EP4324485A1 (en) 2022-08-15 2024-02-21 Branca Banus Ltd A method for the production of pegylated hyperbranched poly( -amino ester)s, pegylated hyperbranched poly( -amino ester)s produced by those methods and their use in enhanced nucleic acid delivery

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180424A (en) * 1991-10-07 1993-01-19 Westvaco Corporation Michael addition aminopolyester resins as dilution extenders for zinc-containing metal resinate inks
US6998115B2 (en) 2000-10-10 2006-02-14 Massachusetts Institute Of Technology Biodegradable poly(β-amino esters) and uses thereof
EP1874844A4 (en) * 2005-04-29 2010-03-24 Agency Science Tech & Res HYPERRAMIFIED POLYMERS AND THEIR APPLICATIONS
EP2046266A4 (en) * 2006-07-21 2009-11-04 Massachusetts Inst Technology ENDMODICIFIED POLY (BETA AMINO ESTER) AND ITS USE

Also Published As

Publication number Publication date
PT3177670T (pt) 2020-04-24
EP3738992A1 (en) 2020-11-18
EP3177670A1 (en) 2017-06-14
HRP20200633T1 (hr) 2020-08-07
ES2785248T3 (es) 2020-10-06
HUE049704T2 (hu) 2020-10-28
RS60335B1 (sr) 2020-07-31
CY1122850T1 (el) 2021-05-05
US20170216455A1 (en) 2017-08-03
LT3177670T (lt) 2020-06-25
GB201413907D0 (en) 2014-09-17
WO2016020474A1 (en) 2016-02-11
SI3177670T1 (sl) 2020-07-31
EP3177670B1 (en) 2020-03-18
PL3177670T3 (pl) 2020-07-13

Similar Documents

Publication Publication Date Title
DK3177670T3 (da) Hyperforgrenet poly(beta-aminoester) til genterapi
DK3072835T3 (da) Fremgangsmåde til fremføring
DK3125898T3 (da) Farmakofor til trail-induktion
DK3006072T3 (da) Karadgang
CL2016002165A1 (es) Compuestos de aminocarbonilcarbamato
DE112015001664A5 (de) Betätigungsaktuator
BR112016030730A2 (pt) Composto
FR3025617B1 (fr) Architecture bi-voies
DK3191466T3 (da) Azetidinyloxyphenylpyrrolidinforbindelser
DK3199175T3 (da) Farmaceutisk sammensætning til injektion
DK3230929T3 (da) Forbedringer til tælleranordninger
DK3164716T3 (da) Fremgangsmåde til diagnosticering af neurodegenerative sygdomme
UA31197S (uk) Таблетка
KR20180084810A (ko) 정제 세트
DK3148993T3 (da) Fremgangsmåde til fremstilling af thiazolderivater
DK3149422T3 (da) Anordning til fremstilling af cementklinker
BR112016026725A2 (pt) Derivados de aminoéster
DK3148976T3 (da) Fremgangsmåde til fremstilling af dihydroisoxazolderivater
DE112015001633A5 (de) Betätigungsaktuator
DK2942098T3 (da) Forbedret fremgangsmåde til fjernelse af nitrit
DK3143028T3 (da) Fremgangsmåde til fremstilling af penamer
BR112016027901A2 (pt) Compostos
DK3053873T3 (da) Gjordsystem
DE112015004618A5 (de) Garnitur
UA32369S (uk) Етикетка для круасанів